中國聖牧(01432.HK)預期年度由虧轉盈逾1億元
格隆匯3月9日丨中國聖牧(01432.HK)公佈,公司預期截至2019年12月31日止年度集團將取得公司除所得税後溢利不少於人民幣1億元(2018年度經審核的公司虧損淨額:約人民幣23.11億元)及公司權益持有人應占綜合虧損轉為盈利,主要歸因於:(i)截至2018年12月31日止公司的下游業務產生金融及合約資產減值虧損人民幣11.12億元,公司已於2019年5月20日完成出售從事下游業務的內蒙古聖牧高科奶業有限公司51%股權,所以該項金融及合約資產減值並不適用於本期間;(ii)2019年中國原料奶售價相比2018年平穩上升,公司於2019年全年的原料奶售價亦相比上年上升;及(iii)因2019年度原料奶售價及牛羣結構較2018年均向好,2019年取得生物資產公平值減銷售費用的變動產生的虧損較2018年度淨虧損人民幣13.22億元有所減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.